Surgical Innovations Group plc (AIM:SUN)
London · Delayed Price · Currency is GBP · Price in GBX 0.4677
-0.0073 (-1.54%)
May 28, 2026, 8:22 AM GMT
AIM:SUN Market Cap
AIM:SUN has a market cap or net worth of 4.43 million as of May 28, 2026. Its market cap has decreased by -26.92% in one year.
Market Cap
4.43M
Enterprise Value
4.28M
Revenue
11.60M
Ranking
n/a
PE Ratio
n/a
Stock Price
0.47
Market Cap Chart
Since February 27, 1992, AIM:SUN's market cap has decreased from 26.51M to 4.43M, a decrease of -83.29%. That is a compound annual growth rate of -5.09%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 27, 2026 | 4.43M | 5.56% |
| Dec 31, 2025 | 4.20M | -18.18% |
| Dec 31, 2024 | 5.13M | -8.33% |
| Dec 29, 2023 | 5.60M | -62.50% |
| Dec 30, 2022 | 14.93M | -31.91% |
| Dec 31, 2021 | 21.92M | 42.42% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| AstraZeneca | 216.52B |
| GSK plc | 77.42B |
| Haleon | 30.29B |
| Smith & Nephew | 9.62B |
| Proteome Sciences | 5.61M |
| CRISM Therapeutics | 5.43M |
| Thalia Therapeutics | 5.41M |
| Theracryf | 4.94M |